Comparison of Treatment Effects Between US and Non-US Study Sites in Multiregional Alzheimer Disease Clinical Trials

Conclusions: It appears that there is no clear evidence to suggest that MRCTs should not be used to study AD.
Source: Therapeutic Innovation and Regulatory Science - Category: Drugs & Pharmacology Authors: Tags: Global Perspectives Source Type: research